According to Evolent Health's latest financial reports and stock price the company's current Operating Margin is -1.49%. At the end of 2024 the company had an Operating Margin of -2.47%.
Year | Operating Margin | Change |
---|---|---|
2024 | -2.47% | -76.06% |
2023 | -10.31% | 124.47% |
2022 | -4.59% | 39.89% |
2021 | -3.28% | -90.82% |
2020 | -35.75% | -25.56% |
2019 | -48.02% | 456.12% |
2018 | -8.64% | -50.84% |
2017 | -17.57% | -81.2% |
2016 | -93.45% | -126.37% |
2015 | 354.35% | |
2013 | 78.03% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | 10.50% | -804.70% | ๐บ๐ธ USA |
![]() | 48.96% | -3,385.91% | ๐ญ๐ฐ Hong Kong |
![]() | 0.69% | -146.26% | ๐บ๐ธ USA |
![]() | 21.38% | -1,534.90% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.